According to Neurocrine Biosciences
's latest financial reports the company has $2.23 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $2.23 B | 30.69% |
2022-12-31 | $1.70 B | 24.29% |
2021-12-31 | $1.37 B | 22% |
2020-12-31 | $1.12 B | 76.83% |
2019-12-31 | $0.63 B | 32.48% |
2018-12-31 | $0.48 B | 29.19% |
2017-12-31 | $0.37 B | 18.19% |
2016-12-31 | $0.31 B | -25.82% |
2015-12-31 | $0.42 B | 103.38% |
2014-12-31 | $0.20 B | 73.32% |
2013-12-31 | $0.12 B | -22% |
2012-12-31 | $0.15 B | 156.94% |
2011-12-31 | $60.08 M | 210.58% |
2010-12-31 | $19.34 M | 389.25% |
2009-12-31 | $3.95 M | -89.25% |
2008-12-31 | $36.77 M | -69.02% |
2007-12-31 | $0.11 B | -62.28% |
2006-12-31 | $0.31 B | -19.33% |
2005-12-31 | $0.39 B | -0.95% |
2004-12-31 | $0.39 B | 0.69% |
2003-12-31 | $0.39 B | 74.41% |
2002-12-31 | $0.22 B | -27.75% |
2001-12-31 | $0.31 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $89.28 B | 3,900.36% | ๐บ๐ธ USA |
AbbVie ABBV | $10.39 B | 365.82% | ๐บ๐ธ USA |
Eli Lilly LLY | $10.86 B | 386.72% | ๐บ๐ธ USA |
Repligen
RGEN | $1.97 B | -11.68% | ๐บ๐ธ USA |
Athersys ATHX | -$36.4 M | -101.63% | ๐บ๐ธ USA |
ANI Pharmaceuticals ANIP | $0.45 B | -79.50% | ๐บ๐ธ USA |
Palatin Technologies PTN | -$11.39 M | -100.51% | ๐บ๐ธ USA |
Royalty Pharma RPRX | $10.08 B | 351.81% | ๐ฌ๐ง UK |